SHWGY (Shandong Weigao Group Medical Polymer Co) Inventories, Raw Materials & Components: $92 Mil (As of Dec. 2025)


SHWGY Shandong Weigao Group Medical Polymer Co Ltd SHWGY
66 GF Score
Price $1.60
GF Value $3.19
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shandong Weigao Group Medical Polymer Co Inventories, Raw Materials & Components?

Shandong Weigao Group Medical Polymer Co SHWGY +6.90% 66 Inventories, Raw Materials & Components is $92 Mil as of Dec. 2025. GuruFocus rates SHWGY with a GF Score™ of 66/100 and a GF Value™ of $3.19 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Shandong Weigao Group Medical Polymer Co's inventories, raw materials & components for the quarter that ended in Dec. 2025 was $92 Mil.

Shandong Weigao Group Medical Polymer Co's quarterly raw materials declined from Dec. 2024 ($91 Mil) to Jun. 2025 ($71 Mil) but then increased from Jun. 2025 ($71 Mil) to Dec. 2025 ($92 Mil).

Shandong Weigao Group Medical Polymer Co's annual raw materials declined from Dec. 2023 ($99 Mil) to Dec. 2024 ($91 Mil) but then increased from Dec. 2024 ($91 Mil) to Dec. 2025 ($92 Mil).

Shandong Weigao Group Medical Polymer Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Group Medical Polymer Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Group Medical Polymer Co Inventories, Raw Materials & Components Chart

Shandong Weigao Group Medical Polymer Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 58.03 94.99 98.79 91.15 92.26

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.79 86.67 91.15 71.03 92.26
SHWGY
66GF Score
Shandong Weigao Group Medical Polymer Co Ltd SHWGY
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Weigao Group Medical Polymer Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $92 Mil mean?
Shandong Weigao Group Medical Polymer Co (SHWGY) has a Inventories, Raw Materials & Components of $92 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors.
Is Shandong Weigao Group Medical Polymer Co's Inventories, Raw Materials & Components too high?
Shandong Weigao Group Medical Polymer Co's current Inventories, Raw Materials & Components is $92 Mil. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's Inventories, Raw Materials & Components compare to ISRG and BDX?
Shandong Weigao Group Medical Polymer Co's Inventories, Raw Materials & Components of $92 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. Shandong Weigao Group Medical Polymer Co's current Inventories, Raw Materials & Components is $92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.19, compared to a current price of $1.60 — trading 50% below its estimated fair value. The current Inventories, Raw Materials & Components is $92 Mil. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGY), the current Inventories, Raw Materials & Components is $92 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Weigao Group Medical Polymer Co (SHWGY) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued. The current stock price of $1.60 is trading 50% below its estimated GF Value™ of $3.19. GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.

Key valuation signals for SHWGY:

  • Inventories, Raw Materials & Components: $92 Mil
  • GF Value™: $3.19 vs. price of $1.60 (50% below fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the SHWGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Weigao Group Medical Polymer Co Business Description

Address No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
66GF Score

Get the complete analysis for SHWGY

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.60
Price
$3.19
GF Value